FDA Investigator Christina Capacci Daniel, PhD
Christina Capacci Daniel, PhD has conducted inspections on 10 sites in 7 countries as of 30 Apr 2018. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
10
Last Inspection Date:
30 Apr 2018
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
Ireland,
United States of America,
Switzerland,
Austria,
Germany,
Puerto Rico,
Taiwan
FDA Investigators that have inspected at least one site in common with Christina Capacci Daniel, PhD:
Aimee Cunningham, PhD,
Amy Devlin, PhD,
Angelica M Hernandez,
Anissa M Cheung,
Anna M Brannen,
Anthony C Warchut,
Arie C Menachem,
Ariel Cruz Figueroa,
Arlene M Badillo,
Arthur T Ogdahl,
Arwa S El Hagrasy,
Bethany L Subel,
Binh T Nguyen,
Bogdan Kurtyka,
Brenda P King,
Brentley S Collins,
Bruce H Mccullough,
Burnell M Henry,
Byeongtaek Oh,
Camerson E Moore,
Caryn M Mcnab,
Celia N Cruz,
Charles R Cote, RIC,
Christian D Lynch (CDL),
Christopher Downey, PhD,
Christopher T Middendorf,
Craig T Rybus,
Cynthia T Cain,
Darin S Wiegers,
Dawn M Braswell,
Dennis Cantellops Paite,
Donna Christner,
Douglas C Kovacs,
Dr. Chunchang Fang,
Dr. Zhihao Qiu (Peter), PhD,
Edmund F Mrak, Jr,
Ekaterina Allen,
Elizabeth Ll Edwards,
Ellen P Madigan,
Emilie E Kahn,
Emily J Orban,
Francis A Guidry,
Gene D Arcy,
Gunther Boekhoudt, PhD,
Iraida Ortiz,
Ivis L Negron,
James L Dunnie, Jr,
Jee Chung, PhD,
Jennifer M Gogley,
Joan A Loreng,
Jon P Antoniou,
Jorge L Guadalupe,
Jose A Lopez,
Jose A Moreno,
José E Meléndez,
Jose Velez,
Joshua P Wireman,
Joyce A Rockwell,
Julie D Bringger,
Junho Pak,
Justine M Corson,
Kara A Scheibner, PhD,
Kathleen R Jones, PhD,
Kenneth E Felkley,
Kenneth H Williams,
Kumar G Janoria,
Lauren N Howard,
Lauren N Smith,
Laurimer Kuilan Torres,
LCDR Chad N Thompson,
LCDR Debra Emerson,
Libia M Lugo,
Lindsey M Schwierjohann,
Lisa M Lopez,
Logan T Williams,
Luis Mburgos Medero,
Marianne Allen,
Mark E Parmon,
Martha T Olone,
Marvin D Jones,
Maxwell Van Tassell, PhD,
Megan A Haggerty,
Michael A Charles,
Michael P Sheehan,
Michael R Klapal,
Michele L Forster, PhD,
Michele Perry Williams,
Michelle M Noe Varga,
Monique C Lo,
Mra Davism,
Mra V Millarw,
Myriam M Sosa,
Nailing Zhang,
Neal L Adams,
Nebil A Oumer,
Nicholas A Violand,
Nicholas L Paulin,
Noreen Muñiz,
Ogechi C Nna,
Omotunde O Osunsanmi,
Pamela L Ogonowski,
Paraluman S Leonin,
Paranthaman Senthamaraikannan,
Patrick C Klotzbuecher,
Paula A Trost,
Prabhu P Raju,
Pratik S Upadhyay, DDC,
Priscilla M Pastrana,
Qin Xu,
Ramon A Hernandez,
Raquel Gonzalez Rivera,
Rebeca M Melendez,
Rebecca Rodriguez,
Regina T Brown,
Richard H Penta,
Richard W Thornton,
Robert J Martin,
Roger F Zabinski,
Rose Xu,
Samantha J Bradley,
Samina S Khan,
Sandra P White,
Santiago Gallardo Johnson,
Sean R Marcsisin,
Seth A Mailhot,
Sharmista Chatterjee,
Shawn E Larson,
Shirley S Wen,
Sneha S Patel,
Stacey S Degarmo,
Steven Fong, MS, PhD,
Steven P Eastham,
Susan M Jackson,
Susan T Hadman,
Tarun D Mehta,
Thomas J Arista,
Tonia F Bernard,
Tracey L Harris,
Travis S Bradley,
Uttaniti Limchumroon (Tom),
Victor J Gangi,
Vilmary Negron Rodriguez,
Vioela J Caze,
Virginia Carroll, PhD,
Walter N Lange,
Wayne E Seifert,
Wen Ning Chan (Sally),
Xiaohui Shen,
Xiaokuang Lai, PhD,
Yanming An, PhD,
Ying Zhang,
Yong Hu,
Zachary A Bogorad,
Zachary L Miller,
Zakaria I Ganiyu,
Zhong Li, PhD
Christina Capacci Daniel, PhD's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| August, 2013 | FDA 483 | Patheon Pharmaceuticals Inc. - Form 483, 2013-08-26 |
| February, 2016 | FDA 483 | Janssen Ortho LLC - Form 483, 2016-02-26 |
| February, 2016 | EIR | Janssen Ortho LLC - EIR, 2016-02-26 |
| May, 2018 | FDA 483 Response | Alnylam Pharmaceuticals Inc. - Form 483R, 2018-05-18 |
| May, 2018 | FDA 483 | Alnylam Pharmaceuticals Inc. - Form 483, 2018-05-04 |
| July, 2014 | FDA 483 | BORA PHARMACEUTICAL LABORATORIES INC. - Form 483, 2014-07-26 |
| September, 2017 | FDA 483 | Vertex Pharmaceuticals Incorporated - Form 483, 2017-09-07 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more